SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092745
Filing Date
2024-08-07
Accepted
2024-08-07 16:05:35
Documents
91
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cprx-20240630.htm   iXBRL 10-Q 2001245
2 EX-10.1 cprx-ex10_1.htm EX-10.1 269708
3 EX-31.1 cprx-ex31_1.htm EX-31.1 13231
4 EX-31.2 cprx-ex31_2.htm EX-31.2 13264
5 EX-32.1 cprx-ex32_1.htm EX-32.1 9151
6 EX-32.2 cprx-ex32_2.htm EX-32.2 9166
  Complete submission text file 0000950170-24-092745.txt   10230488

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cprx-20240630.xsd EX-101.SCH 1335872
94 EXTRACTED XBRL INSTANCE DOCUMENT cprx-20240630_htm.xml XML 1969092
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 241183575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)